Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Unknown Primary × Drug Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 14 Carcinoma, Non-Small-Cell Lung 13 Neoplasms 10 Head and Neck Neoplasms 8 Carcinoma, Squamous Cell 8 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Glioblastoma 7 Colorectal Neoplasms 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Recurrence 5 Pancreatic Neoplasms 5 Melanoma 5 Leukemia 5 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Fallopian Tube Neoplasms 4 Anemia, Refractory, with Excess of Blasts 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Rectal Neoplasms 3 Lymphoma, Follicular 3 Colonic Neoplasms 3 Brain Neoplasms 3 Treatment 2 Sarcoma 2 Pleural Effusion, Malignant 2 Pharyngeal Neoplasms 2

Interventions

Paclitaxel 6 Carboplatin 6 Gemcitabine 3 Irinotecan 2 Erlotinib Hydrochloride 2 Capecitabine 2 Bevacizumab 2 sintilimab 1 pertuzumab 1 pemigatinib 1 pembrolizumab 1 olaparib 1 ivosidenib 1 ipatasertib 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1 entrectinib 1 cobimetinib 1 belinostat 1 atezolizumab 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alectinib 1 Vemurafenib 1 Oxaliplatin 1 HhAntag691 1 Everolimus 1 Etoposide 1 Cisplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡